Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype-Reference-Cited by-同舟云学术

Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype

Published:2016-03-18 Issue:10 Volume:43 Page:1048-1059
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Kagami T.¹,Sahara S.¹,Ichikawa H.¹,Uotani T.¹,Yamade M.¹,Sugimoto M.¹,Hamaya Y.²,Iwaizumi M.¹,Osawa S.³,Sugimoto K.¹,Miyajima H.¹,Furuta T.⁴

Affiliation:

1. First Department of Medicine; Hamamatsu University School of Medicine; Hamamatsu Japan

2. Department of Clinical Oncology; Hamamatsu University School of Medicine; Hamamatsu Japan

3. Department of Endoscopic and Photodynamic Medicine; Hamamatsu University School of Medicine; Hamamatsu Japan

4. Center for Clinical Research; Hamamatsu University School of Medicine; Hamamatsu Japan

Funder

Ministry of Education, Culture, Sports, Science, and Technology

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13588/fullpdf

Reference63 articles.

1. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease;Walsh;N Engl J Med,1995

2. Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole;Furuta;Clin Pharmacol Ther,2002

3. Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H. pylori infection;Furuta;Clin Gastroenterol Hepatol,2005

4. Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy;Sugimoto;Helicobacter,2007

5. Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation recruited from an Oriental population;Sohn;J Pharmacol Exp Ther,1992

Cited by 183 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review;Gastroenterology;2024-09

2. Vonoprazan Dual or Triple Therapy Versus Bismuth‐Quadruple Therapy as First‐Line Therapy for Helicobacter pylori Infection: A Three‐Arm, Randomized Clinical Trial;Helicobacter;2024-09

3. Safety of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease;Expert Opinion on Drug Metabolism & Toxicology;2024-08-27

4. Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments;Current Gastroenterology Reports;2024-08-15

5. The multicenter real-world report of the efficacies of 14-day esomeprazole-based and rabeprazole-based high-dose dual therapy in first-line Helicobacter pylori eradication in Taiwan;Journal of Microbiology, Immunology and Infection;2024-08